KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

New Strong Sell Stocks for December 23rd

09:02am, Friday, 23'rd Dec 2022
SGRP, LFCR and MD have been added to the Zacks Rank #5 (Strong Sell) List on December 23, 2022.
Pediatrix's (MD) Q3 results reflect volume constraints and an elevated expense level. Adjusted EBITDA is now expected within $240-$245 million, down from the earlier view of $260-$270 million.
Pediatrix Medical Group, Inc. (NYSE:MD ) Q3 2022 Earnings Conference Call November 3, 2022 9:00 AM ET Corporate Participants Charles Lynch - Investor Relations Mark Ordan - Chief Executive Officer Mar
Pediatrix Medical Group (MD) delivered earnings and revenue surprises of -24.53% and 4.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the sto
Recovering volumes, improved admissions, growing health awareness and wide utilization of technologies in the third quarter are expected to have aided healthcare stocks like Humana (HUM), Teladoc (TDO
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
MD vs. GDRX: Which Stock Is the Better Value Option?

Pediatrix: These 5 Graphs Suggest It's A Buy

12:52pm, Thursday, 29'th Sep 2022
Pediatrix continues to incur a heavy downside on the chart with the stock down 37% this year to date. Despite the selloff, MD's bottom-line fundamentals continue to look increasingly attractive in the

7 Cheap Stocks That Could Increase 10X by 2027

02:23pm, Wednesday, 31'st Aug 2022
As I was preparing to write about cheap stocks to buy that could increase by ten times over the next few years, I wondered what measuring stick I should use to appropriately identify names that were d
Pediatrix's (MD) second-quarter results reflect growth in patient volumes. Adjusted EBITDA is expected within $260-$270 million for 2022.
Pediatrix Medical Group, Inc. (NYSE:MD ) Q2 2022 Earnings Conference Call August 4, 2022 9:00 AM ET Corporate Participants Charles Lynch - Investor Relations Mark Ordan - Chief Executive Officer Marc

Mednax (MD) Q2 Earnings Match Estimates

09:02am, Thursday, 04'th Aug 2022
Mednax (MD) delivered earnings and revenue surprises of 0% and 1.34%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Pediatrix has idiosyncratic risk drivers that have yet to be priced in at the market level, by estimate. Price action points to a reversal from recent lows and trend indicators suggest a newly formed
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE